Athens IVD Reagents in Action
From fueling biomarker research and validation to enabling sensitive immunoassays, reliable native proteins allow you to elevate diagnostic science across diverse conditions.
R&D teams worldwide are using our high-purity proteins to advance diagnostics:
- Breath-based biosensors1 for lower respiratory tract infection detection
- Rapid ELISA assays2 for accurate measurement of lipoprotein(a), an important cardiovascular risk factor
- In vivo theranostics3 development for Alzheimer’s disease
- High-throughput clinical chemistry formats, including nephelometry and turbidimetry
In recent years, Athens’ proteins have enabled investigations into biomarkers, like butyrylcholinesterase (BChE)1,3—a potential indicator of sudden infant death syndrome (SIDS) and a promising drug target for Alzheimer’s disease treatment.
With Athens, your R&D teams have a dependable foundation for assays, biosensors, calibrators, controls, and custom antibody production.
Here's how:
- Native structure and activity, enabling biologically relevant assays and antibody generation
- High purity and reproducibility, giving teams confidence in signal stability and reducing lot-to-lot variability
- High yields and batch reservations from single or pooled donors, supporting long-term programs
- Optimized purification processes that maintain form, fit, and function from mg to kg, simplifying revalidation and ensuring IVD raw material consistency at every scale
Our experts work closely with you to help solve complex technical problems and deliver tailored solutions that stand up to today’s clinical chemistry challenges.
Want a deeper look?
See peer-reviewed studies showing how our IVD reagents advance biomarker assay and diagnostic development.
*1. Chen, et al. A breath-based in vitro diagnostic assay for the detection of lower respiratory tract infections. PNAS Nexus, 2024, 3, 350. https://doi.org/10.1093/pnasnexus/pgae350 / Maryland, USA
*2. Contois, et al. Lipoprotein(a) particle number assay without error from apolipoprotein(a) size isoforms. Clinica Chimica Acta 505, 2020, 119–124. https://doi.org/10.1016/j.cca.2020.02.030 / Sun Diagnostics, USA
*3. Wang, et al. Butyrylcholinesterase-Activated Near-Infrared Fluorogenic Probe for In Vivo Theranostics of Alzheimer’s Disease. J. Med. Chem. 2024, 67, 6793−6809. https://doi.org/10.1021/acs.jmedchem.4c00355/ China Pharmaceutical University
